Literature DB >> 15446819

Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction.

R Venkatapathy1, C J Moudgal, R M Bruce.   

Abstract

The performance of the rat chronic lowest observed adverse effect level (LOAEL, the lowest exposure level at which there are biologically significant increases in the severity of adverse effects) model in Toxicity Prediction by Komputer Assisted Technology (TOPKAT), a commercial quantitative structure-activity relationship software package, was tested on a database of chemicals that are of interest to the U.S. EPA's Office of Pesticide Programs. The testing was repeated on a database of chemicals from three U.S. EPA sources that report peer-reviewed LOAELs. The results of this study were also contrasted with the results of the testing performed during TOPKAT's model-building process. Copyright 2004 American Chemical Society

Entities:  

Mesh:

Year:  2004        PMID: 15446819     DOI: 10.1021/ci049903s

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  14 in total

1.  True prediction of lowest observed adverse effect levels.

Authors:  R García-Domenech; J V de Julián-Ortiz; E Besalú
Journal:  Mol Divers       Date:  2006-05-24       Impact factor: 2.943

2.  In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.

Authors:  Fabiola Pizzo; Domenico Gadaleta; Emilio Benfenati
Journal:  Methods Mol Biol       Date:  2022

3.  1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies.

Authors:  Mohamed Hagras; Marwa A Saleh; Rogy R Ezz Eldin; Abdelrahman A Abuelkhir; Emad Gamil Khidr; Ahmed A El-Husseiny; Hesham A El-Mahdy; Eslam B Elkaeed; Ibrahim H Eissa
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

4.  A novel two-step hierarchical quantitative structure-activity relationship modeling work flow for predicting acute toxicity of chemicals in rodents.

Authors:  Hao Zhu; Lin Ye; Ann Richard; Alexander Golbraikh; Fred A Wright; Ivan Rusyn; Alexander Tropsha
Journal:  Environ Health Perspect       Date:  2009-04-03       Impact factor: 9.031

5.  Use of in vitro HTS-derived concentration-response data as biological descriptors improves the accuracy of QSAR models of in vivo toxicity.

Authors:  Alexander Sedykh; Hao Zhu; Hao Tang; Liying Zhang; Ann Richard; Ivan Rusyn; Alexander Tropsha
Journal:  Environ Health Perspect       Date:  2010-10-27       Impact factor: 9.031

6.  Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties.

Authors:  Monika Batke; Martin Gütlein; Falko Partosch; Ursula Gundert-Remy; Christoph Helma; Stefan Kramer; Andreas Maunz; Madeleine Seeland; Annette Bitsch
Journal:  Front Pharmacol       Date:  2016-09-21       Impact factor: 5.810

Review 7.  Building a virtual ligand screening pipeline using free software: a survey.

Authors:  Enrico Glaab
Journal:  Brief Bioinform       Date:  2015-06-20       Impact factor: 11.622

8.  Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation.

Authors:  Sheng Guo; Hang Xie; Yu Lei; Bin Liu; Li Zhang; Yechun Xu; Zhili Zuo
Journal:  Bioorg Chem       Date:  2021-02-24       Impact factor: 5.307

9.  In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro).

Authors:  Mohamed S Alesawy; Abdallah E Abdallah; Mohammed S Taghour; Eslam B Elkaeed; Ibrahim H Eissa; Ahmed M Metwaly
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

10.  Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).

Authors:  Amr El-Demerdash; Ahmed M Metwaly; Afnan Hassan; Tarek Mohamed Abd El-Aziz; Eslam B Elkaeed; Ibrahim H Eissa; Reem K Arafa; James D Stockand
Journal:  Biomolecules       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.